A new series of mixed ligand complexes synthesized and characterized using of azo ligand derived from (5-methyl— imidazole) with (8-hydroxy quinolone). New mix-ligand structures and their transitional metal complexes were fully characterized using several techniques, including molar conductance, elemental analysis (C.H.N), electronic spectral, magnetic measurements, 1HNMR, spectral studies, and mass spectra. The data shows that these complexes have a composition of [ML(8-HQ) Cl2] H2O where M = Co(II), Zn(II), Cu(II), X=0, and Ni(II), X=1, [ML(8-HQ)] Cl. where M=Pd. The electronic spectral data and magnetic susceptibility calculations of the complexes indicate that the octahedral geometry of all complexes, except for the Pd(II) complex, indicates a planar-square geometry. The results demonstrate that the nitrogen of the imidazole ring and azo nitrogen atom of the primary ligand are coordination sites with a nitrogen atom and oxygen atom of a secondary ligand of the (8-HQ) in the basic medium. Biological effects of the palladium (II) complex are screening against human breast cancer (MCF-7 and AMJ-13) and normal cells (HBL) were examined, which indicated colon cancer cell line LS-174. The results show the highest activity effect for the complex.
This paper explained synthesis of new ligand 1-(4-((4,5-bis (4-methoxy phenyl)-1H-imidazol-2-yl)diazenyl)phenyl)-3-(4-bromophenyl)prop-2-en-1-one (LBr), this ligand coordinates with (Co, Ni, Cu, Zn, Hg and Pd)(II) in mole ratio (1:2), the ligand characterized by numerous spectroscopic techniques such (UV-Visible, H-NMR, Mass, IR, C.H.N), while its complexes characterized by (UV-Visible, IR, C.H.N., electrical molar conductivity and magnetic susceptibility). The results of this study proposed an Octahedral geometry for all complexes excepting Pd(II) complex was square planer antitumor activity against breast cancer line (MCF-7) was gauged using Pd(II)complex, which has been shown selective cytotoxicity destroying cancer cells, this decides Pd(II) complex could be used to create anti-cancer medication in the forthcoming after compered between ligand has been prepared and this complex in cytotoxic effects.
This academic research consists of mixed ligands 8-hydroxy quinolone and new azo ligand [ (E)-2-((4-methoxyphenyl) diazenyl)-4-methyl-1H-imidazole](PMI) both of them coordinated with (Cu ,Ni and Pd)(II) , the mole ratio was (1:1:1) . the suggestion geometrical structures of mixed ligands and its complexes have been studied by (FT.IR, UV-Visible, 1H-NMR, Mass and elementary analysis (C.H.N) ) In addition, an electrical molar conductivity and magnetic susceptibility used for complexes . The results of analytical studies evidence an Octahedral geometries of (Cu, Ni) (II) complexes while , Square planer of Pd(II) complex .It seems to be there is noticeable inhibition of cancerous cells of human Thyroid cancer (FTC133 ) compared to normal cells , which mentions to the cytotoxicity of Pd(II) complex ., this results gave good information about including good inhibition against some types of tumor like thyroid cancer and it gave decreasing in size of tumor.
This Case study to Solve social problem like The begging in street and poverty problem for small cities., This study investigated the prevalence and consequences of street begging among adults and children in small towns, Descriptive of this scientific study was adopted for the many cases in many small and poor towns and Finding solutions Of The Begging Problem :
Name Problem: Treatment of Social problem (The Begging)
Type of Study: Scientific Study for Treatment of Social Problem (The Begging)
Aim of Scientific Study: Finding solutions of The Begging Problem
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.